SIMILAR PATTERNS OF AMINO ACIDS FOR 1A4G_A_ZMRA466

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ct9 ASPARAGINE
SYNTHETASE B


(Escherichia
coli)
PF00733
(Asn_synthase)
PF13537
(GATase_7)
5 ARG A 309
ARG A 498
GLU A 499
ALA A 511
GLU A 502
None
1.42A 1a4gA-1ct9A:
undetectable
1a4gA-1ct9A:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ms8 TRANS-SIALIDASE

(Trypanosoma
cruzi)
PF13385
(Laminin_G_3)
PF13859
(BNR_3)
6 ARG A  35
ASP A  59
GLU A 230
ARG A 245
ARG A 314
TYR A 342
DAN  A 700 (-3.0A)
DAN  A 700 (-2.7A)
DAN  A 700 (-3.3A)
DAN  A 700 (-2.8A)
DAN  A 700 (-3.0A)
DAN  A 700 (-3.5A)
0.87A 1a4gA-1ms8A:
23.8
1a4gA-1ms8A:
19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mz5 SIALIDASE

(Trypanosoma
rangeli)
PF13385
(Laminin_G_3)
PF13859
(BNR_3)
6 ARG A  36
ASP A  60
GLU A 231
ARG A 246
ARG A 315
TYR A 343
None
0.60A 1a4gA-1mz5A:
24.1
1a4gA-1mz5A:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nmb N9 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
10 ARG N 118
GLU N 119
ARG N 224
GLU N 227
ALA N 246
GLU N 276
GLU N 277
ARG N 292
ASN N 294
TYR N 406
None
0.73A 1a4gA-1nmbN:
53.6
1a4gA-1nmbN:
28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nmb N9 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
10 ARG N 118
GLU N 119
ARG N 224
GLU N 227
ALA N 246
GLU N 277
ARG N 292
ASN N 294
ARG N 371
TYR N 406
None
0.63A 1a4gA-1nmbN:
53.6
1a4gA-1nmbN:
28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nmb N9 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
10 ARG N 118
GLU N 119
ASP N 151
ARG N 224
GLU N 227
GLU N 276
GLU N 277
ARG N 292
ASN N 294
TYR N 406
None
0.83A 1a4gA-1nmbN:
53.6
1a4gA-1nmbN:
28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nmb N9 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
10 ARG N 118
GLU N 119
ASP N 151
ARG N 224
GLU N 227
GLU N 277
ARG N 292
ASN N 294
ARG N 371
TYR N 406
None
0.75A 1a4gA-1nmbN:
53.6
1a4gA-1nmbN:
28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nmb N9 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
5 ARG N 118
GLU N 119
ASP N 151
ASN N 347
TYR N 406
None
1.20A 1a4gA-1nmbN:
53.6
1a4gA-1nmbN:
28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nmb N9 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
5 GLU N 227
ALA N 246
ARG N 292
ASN N 294
TYR N 406
None
1.25A 1a4gA-1nmbN:
53.6
1a4gA-1nmbN:
28.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1v0z NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
12 ARG A 124
GLU A 125
ASP A 157
ARG A 231
GLU A 234
ALA A 253
GLU A 283
GLU A 284
ARG A 299
ASN A 301
ARG A 378
TYR A 412
None
0.58A 1a4gA-1v0zA:
53.8
1a4gA-1v0zA:
32.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1vcj NEURAMINIDASE

(Influenza B
virus)
PF00064
(Neur)
11 ARG A 116
GLU A 117
ASP A 149
ARG A 223
GLU A 226
ALA A 245
GLU A 276
ARG A 292
ASN A 294
ARG A 374
TYR A 409
IBA  A   1 (-3.3A)
IBA  A   1 (-3.9A)
IBA  A   1 (-3.6A)
IBA  A   1 ( 4.5A)
IBA  A   1 (-3.9A)
IBA  A   1 ( 3.9A)
IBA  A   1 (-3.9A)
IBA  A   1 (-3.5A)
IBA  A   1 ( 3.9A)
IBA  A   1 (-3.2A)
None
0.49A 1a4gA-1vcjA:
73.9
1a4gA-1vcjA:
94.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1vcj NEURAMINIDASE

(Influenza B
virus)
PF00064
(Neur)
7 ARG A 116
GLU A 117
ASP A 149
ARG A 223
GLU A 275
GLU A 276
TYR A 409
IBA  A   1 (-3.3A)
IBA  A   1 (-3.9A)
IBA  A   1 (-3.6A)
IBA  A   1 ( 4.5A)
IBA  A   1 (-4.1A)
IBA  A   1 (-3.9A)
None
1.22A 1a4gA-1vcjA:
73.9
1a4gA-1vcjA:
94.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1vcj NEURAMINIDASE

(Influenza B
virus)
PF00064
(Neur)
5 GLU A 226
ALA A 245
ARG A 292
ASN A 294
TYR A 409
IBA  A   1 (-3.9A)
IBA  A   1 ( 3.9A)
IBA  A   1 (-3.5A)
IBA  A   1 ( 3.9A)
None
1.18A 1a4gA-1vcjA:
73.9
1a4gA-1vcjA:
94.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w8o BACTERIAL SIALIDASE

(Micromonospora
viridifaciens)
PF00754
(F5_F8_type_C)
PF10633
(NPCBM_assoc)
PF13088
(BNR_2)
5 ARG A  68
GLU A 260
ARG A 276
ARG A 342
TYR A 370
CIT  A1649 ( 2.6A)
GOL  A1651 (-3.6A)
CIT  A1649 ( 2.7A)
CIT  A1649 ( 2.9A)
CIT  A1649 (-4.5A)
0.32A 1a4gA-1w8oA:
25.8
1a4gA-1w8oA:
20.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1xog NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
11 ARG A 119
GLU A 120
ASP A 152
ARG A 226
GLU A 229
ALA A 248
GLU A 279
ARG A 294
ASN A 296
ARG A 372
TYR A 406
ABW  A1000 (-3.2A)
ABW  A1000 (-3.7A)
ABW  A1000 (-3.7A)
None
ABW  A1000 ( 4.0A)
ABW  A1000 ( 3.8A)
ABW  A1000 (-4.5A)
ABW  A1000 (-3.4A)
ABW  A1000 ( 4.0A)
ABW  A1000 (-2.8A)
ABW  A1000 (-4.9A)
0.61A 1a4gA-1xogA:
53.4
1a4gA-1xogA:
30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1xog NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
5 ARG A 119
GLU A 120
ASP A 152
ASN A 348
TYR A 406
ABW  A1000 (-3.2A)
ABW  A1000 (-3.7A)
ABW  A1000 (-3.7A)
None
ABW  A1000 (-4.9A)
0.99A 1a4gA-1xogA:
53.4
1a4gA-1xogA:
30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1xog NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
5 ARG A 226
GLU A 229
ALA A 248
GLU A 278
ASN A 296
None
ABW  A1000 ( 4.0A)
ABW  A1000 ( 3.8A)
ABW  A1000 (-4.1A)
ABW  A1000 ( 4.0A)
0.98A 1a4gA-1xogA:
53.4
1a4gA-1xogA:
30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1xog NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
5 GLU A 120
ALA A 248
ARG A 294
ASN A 296
TYR A 406
ABW  A1000 (-3.7A)
ABW  A1000 ( 3.8A)
ABW  A1000 (-3.4A)
ABW  A1000 ( 4.0A)
ABW  A1000 (-4.9A)
1.24A 1a4gA-1xogA:
53.4
1a4gA-1xogA:
30.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bf6 EXO-ALPHA-SIALIDASE

(Clostridium
perfringens)
PF13088
(BNR_2)
6 ARG A 266
ASP A 291
GLU A 539
ARG A 555
ARG A 615
TYR A 655
SIA  A1692 (-2.7A)
SIA  A1692 (-2.8A)
SIA  A1692 ( 3.9A)
SIA  A1692 (-2.9A)
SIA  A1692 (-3.1A)
SIA  A1692 (-4.2A)
0.47A 1a4gA-2bf6A:
25.0
1a4gA-2bf6A:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f28 SIALIDASE 2

(Homo sapiens)
PF13088
(BNR_2)
5 ARG A  21
GLU A 218
ARG A 237
ARG A 304
TYR A 334
None
0.42A 1a4gA-2f28A:
25.2
1a4gA-2f28A:
21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fpg SUCCINYL-COA LIGASE
[GDP-FORMING]
ALPHA-CHAIN,
MITOCHONDRIAL
SUCCINYL-COA LIGASE
[GDP-FORMING]
BETA-CHAIN,
MITOCHONDRIAL


(Sus scrofa)
PF00549
(Ligase_CoA)
PF02629
(CoA_binding)
PF08442
(ATP-grasp_2)
5 GLU A 224
ALA A 247
GLU A 223
ARG A 161
ARG B 123
None
1.48A 1a4gA-2fpgA:
undetectable
1a4gA-2fpgA:
20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gfg BH2851

(Bacillus
halodurans)
PF01928
(CYTH)
5 ARG A 184
GLU A 149
GLU A 151
GLU A   6
GLU A   8
EDO  A 503 (-4.2A)
EDO  A 503 (-3.0A)
UNL  A 500 ( 2.8A)
UNL  A 500 ( 3.9A)
EDO  A 503 ( 3.9A)
1.42A 1a4gA-2gfgA:
undetectable
1a4gA-2gfgA:
19.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2htv NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
9 ARG A 118
ARG A 224
GLU A 227
GLU A 276
GLU A 277
ARG A 292
ASN A 294
ARG A 371
TYR A 406
None
0.61A 1a4gA-2htvA:
51.8
1a4gA-2htvA:
36.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2htv NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
7 ARG A 118
ASP A 151
ARG A 224
GLU A 227
GLU A 277
ARG A 371
TYR A 406
None
0.67A 1a4gA-2htvA:
51.8
1a4gA-2htvA:
36.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2htv NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
7 GLU A 119
ARG A 224
GLU A 276
GLU A 277
ARG A 292
ASN A 294
TYR A 406
None
1.06A 1a4gA-2htvA:
51.8
1a4gA-2htvA:
36.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vdw VACCINIA VIRUS
CAPPING ENZYME D1
SUBUNIT


(Vaccinia virus)
PF03291
(Pox_MCEL)
5 ARG A 655
ASP A 598
GLU A 652
ALA A 625
ARG A 548
SAH  A1846 (-3.4A)
SAH  A1846 (-3.1A)
None
SAH  A1846 ( 4.9A)
SAH  A1846 (-3.2A)
1.48A 1a4gA-2vdwA:
undetectable
1a4gA-2vdwA:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w20 SIALIDASE A

(Streptococcus
pneumoniae)
PF13088
(BNR_2)
6 ARG A 347
ASP A 372
GLU A 647
ARG A 663
ARG A 721
TYR A 752
None
0.58A 1a4gA-2w20A:
25.1
1a4gA-2w20A:
21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xzi EXTRACELLULAR
SIALIDASE/NEURAMINID
ASE, PUTATIVE


(Aspergillus
fumigatus)
PF13088
(BNR_2)
6 ARG A  59
ASP A  84
GLU A 249
ARG A 265
ARG A 322
TYR A 358
KDM  A 500 (-2.7A)
KDM  A 500 (-2.8A)
KDM  A 500 (-3.6A)
KDM  A 500 (-2.7A)
KDM  A 500 ( 3.0A)
KDM  A 500 (-4.5A)
0.38A 1a4gA-2xziA:
12.5
1a4gA-2xziA:
22.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ckz NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
11 ARG A 118
GLU A 119
ASP A 151
ARG A 224
GLU A 227
GLU A 276
GLU A 277
ARG A 292
ASN A 294
ARG A 371
TYR A 406
ZMR  A 469 (-2.9A)
ZMR  A 469 (-3.5A)
ZMR  A 469 (-3.5A)
ZMR  A 469 (-4.4A)
ZMR  A 469 (-3.5A)
ZMR  A 469 (-2.8A)
ZMR  A 469 (-3.7A)
ZMR  A 469 (-3.0A)
ZMR  A 469 (-3.9A)
ZMR  A 469 (-2.9A)
ZMR  A 469 (-4.7A)
0.39A 1a4gA-3ckzA:
53.6
1a4gA-3ckzA:
34.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3juu PORPHYRANASE B

(Zobellia
galactanivorans)
PF00722
(Glyco_hydro_16)
5 ARG A  70
GLU A 256
GLU A 161
ASN A 183
TYR A 258
GOL  A 294 (-3.3A)
GOL  A 294 (-2.7A)
GOL  A 294 (-3.1A)
None
None
1.45A 1a4gA-3juuA:
undetectable
1a4gA-3juuA:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pfo PUTATIVE
ACETYLORNITHINE
DEACETYLASE


(Rhodopseudomonas
palustris)
PF01546
(Peptidase_M20)
PF07687
(M20_dimer)
5 ARG A  41
GLU A 178
GLU A 176
ASN A 182
ARG A 380
None
ZN  A 451 (-2.0A)
None
None
None
1.42A 1a4gA-3pfoA:
undetectable
1a4gA-3pfoA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qfi TRANSCRIPTIONAL
REGULATOR


(Enterococcus
faecalis)
PF03816
(LytR_cpsA_psr)
5 ARG A 197
ASP A  70
ARG A 104
ASN A 120
ARG A 209
None
1.50A 1a4gA-3qfiA:
undetectable
1a4gA-3qfiA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sil SIALIDASE

(Salmonella
enterica)
PF13859
(BNR_3)
6 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
0.74A 1a4gA-3silA:
23.5
1a4gA-3silA:
21.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ti8 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
12 ARG A 118
GLU A 119
ASP A 151
ARG A 224
GLU A 227
ALA A 246
GLU A 276
GLU A 277
ARG A 292
ASN A 294
ARG A 371
TYR A 406
LNV  A 901 (-3.0A)
LNV  A 901 (-3.6A)
LNV  A 901 (-3.4A)
LNV  A 901 (-4.1A)
LNV  A 901 (-3.4A)
LNV  A 901 (-3.5A)
LNV  A 901 (-2.9A)
LNV  A 901 ( 3.8A)
LNV  A 901 (-2.8A)
LNV  A 901 (-4.0A)
LNV  A 901 (-2.9A)
LNV  A 901 (-4.8A)
0.38A 1a4gA-3ti8A:
53.9
1a4gA-3ti8A:
36.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tia NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
12 ARG A 118
GLU A 119
ASP A 151
ARG A 224
GLU A 227
ALA A 246
GLU A 276
GLU A 277
ARG A 292
ASN A 294
ARG A 371
TYR A 406
LNV  A 801 (-2.8A)
LNV  A 801 (-3.5A)
LNV  A 801 (-3.4A)
LNV  A 801 (-4.2A)
LNV  A 801 (-3.5A)
LNV  A 801 (-3.4A)
LNV  A 801 (-2.9A)
LNV  A 801 (-3.8A)
LNV  A 801 (-3.0A)
LNV  A 801 (-4.0A)
LNV  A 801 (-2.9A)
LNV  A 801 (-4.4A)
0.43A 1a4gA-3tiaA:
55.2
1a4gA-3tiaA:
28.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zie SEPF-LIKE PROTEIN

(Archaeoglobus
fulgidus)
PF04472
(SepF)
5 ARG A  55
GLU A  52
GLU A  56
ARG A  40
TYR A  38
None
1.15A 1a4gA-3zieA:
undetectable
1a4gA-3zieA:
14.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4b7j NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
9 ARG A 118
GLU A 119
ASP A 151
ARG A 225
GLU A 228
GLU A 277
GLU A 278
ASN A 295
TYR A 402
G39  A1470 (-3.1A)
G39  A1470 (-3.5A)
G39  A1470 (-3.7A)
G39  A1470 (-4.4A)
None
G39  A1470 (-3.7A)
G39  A1470 (-4.2A)
G39  A1470 ( 3.7A)
G39  A1470 (-4.5A)
0.68A 1a4gA-4b7jA:
53.0
1a4gA-4b7jA:
31.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4b7j NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
10 ARG A 118
GLU A 119
ASP A 151
ARG A 225
GLU A 228
GLU A 278
ARG A 293
ASN A 295
ARG A 368
TYR A 402
G39  A1470 (-3.1A)
G39  A1470 (-3.5A)
G39  A1470 (-3.7A)
G39  A1470 (-4.4A)
None
G39  A1470 (-4.2A)
G39  A1470 (-2.9A)
G39  A1470 ( 3.7A)
G39  A1470 (-3.0A)
G39  A1470 (-4.5A)
0.46A 1a4gA-4b7jA:
53.0
1a4gA-4b7jA:
31.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bbw SIALIDASE
(NEURAMINIDASE)


(Bacteroides
thetaiotaomicron)
PF13088
(BNR_2)
PF14873
(BNR_assoc_N)
5 ARG A 204
ASP A 229
GLU A 399
ARG A 415
TYR A 510
None
0.81A 1a4gA-4bbwA:
25.0
1a4gA-4bbwA:
22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bbw SIALIDASE
(NEURAMINIDASE)


(Bacteroides
thetaiotaomicron)
PF13088
(BNR_2)
PF14873
(BNR_assoc_N)
5 ARG A 204
GLU A 399
ARG A 415
ARG A 479
TYR A 510
None
0.58A 1a4gA-4bbwA:
25.0
1a4gA-4bbwA:
22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ckb MRNA-CAPPING ENZYME
CATALYTIC SUBUNIT


(Vaccinia virus)
PF03291
(Pox_MCEL)
PF10640
(Pox_ATPase-GT)
5 ARG A 655
ASP A 598
GLU A 652
ALA A 625
ARG A 548
SAH  A1845 (-3.3A)
SAH  A1845 (-3.5A)
None
SAH  A1845 ( 4.7A)
SAH  A1845 (-3.4A)
1.40A 1a4gA-4ckbA:
undetectable
1a4gA-4ckbA:
19.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4cpn NEURAMINIDASE

(Influenza B
virus)
PF00064
(Neur)
12 ARG A 115
GLU A 116
ASP A 148
ARG A 222
GLU A 225
ALA A 244
GLU A 274
GLU A 275
ARG A 291
ASN A 293
ARG A 373
TYR A 408
ZMR  A 700 (-2.9A)
ZMR  A 700 (-3.5A)
ZMR  A 700 (-3.3A)
ZMR  A 700 (-3.8A)
ZMR  A 700 (-3.5A)
ZMR  A 700 (-3.6A)
ZMR  A 700 (-2.7A)
ZMR  A 700 (-3.4A)
ZMR  A 700 (-2.8A)
ZMR  A 700 ( 3.9A)
ZMR  A 700 (-3.0A)
ZMR  A 700 (-4.6A)
0.29A 1a4gA-4cpnA:
75.0
1a4gA-4cpnA:
94.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fj6 GLYCOSIDE HYDROLASE
FAMILY 33, CANDIDATE
SIALIDASE


(Parabacteroides
distasonis)
PF13859
(BNR_3)
PF14873
(BNR_assoc_N)
6 ARG A 200
ASP A 225
GLU A 395
ARG A 411
ARG A 475
TYR A 506
PO4  A 607 ( 2.6A)
PO4  A 607 ( 3.8A)
PO4  A 607 ( 4.8A)
PO4  A 607 (-2.7A)
PO4  A 607 (-2.8A)
PO4  A 607 (-4.6A)
0.49A 1a4gA-4fj6A:
25.0
1a4gA-4fj6A:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fzh HEMAGGLUTININ-NEURAM
INIDASE


(Avian
avulavirus 1)
PF00423
(HN)
5 ARG A 174
GLU A 401
ARG A 416
ARG A 498
TYR A 526
None
0.71A 1a4gA-4fzhA:
23.2
1a4gA-4fzhA:
20.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h53 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
11 ARG A 118
GLU A 119
ASP A 151
ARG A 224
GLU A 227
ALA A 246
GLU A 276
GLU A 277
ARG A 292
ASN A 294
ARG A 371
SLB  A 512 (-2.7A)
SLB  A 512 (-3.5A)
SLB  A 512 (-3.5A)
SLB  A 512 (-4.2A)
None
SLB  A 512 (-3.3A)
SLB  A 512 (-2.8A)
SLB  A 512 (-2.7A)
SLB  A 512 (-3.1A)
SLB  A 512 ( 4.2A)
SLB  A 512 (-2.9A)
0.47A 1a4gA-4h53A:
55.1
1a4gA-4h53A:
31.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h53 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
5 ARG A 371
ARG A 224
ALA A 246
GLU A 276
GLU A 277
SLB  A 512 (-2.9A)
SLB  A 512 (-4.2A)
SLB  A 512 (-3.3A)
SLB  A 512 (-2.8A)
SLB  A 512 (-2.7A)
1.29A 1a4gA-4h53A:
55.1
1a4gA-4h53A:
31.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hgk SHARK V-NAR ANTIBODY

(Squalus
acanthias)
PF07686
(V-set)
5 ARG C  73
GLU C  66
ARG C  57
ASN C  59
TYR C  74
None
1.39A 1a4gA-4hgkC:
undetectable
1a4gA-4hgkC:
15.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hzz NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
9 ARG A 118
GLU A 119
ASP A 151
ARG A 224
GLU A 227
ALA A 246
GLU A 276
GLU A 277
TYR A 406
G39  A 509 (-3.0A)
G39  A 509 (-3.3A)
G39  A 509 (-3.6A)
G39  A 509 (-4.7A)
None
G39  A 509 ( 4.1A)
G39  A 509 ( 4.1A)
G39  A 509 ( 4.0A)
G39  A 509 (-4.6A)
0.65A 1a4gA-4hzzA:
52.3
1a4gA-4hzzA:
33.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hzz NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
10 ARG A 118
GLU A 119
ASP A 151
ARG A 224
GLU A 227
ALA A 246
GLU A 277
ARG A 292
ARG A 371
TYR A 406
G39  A 509 (-3.0A)
G39  A 509 (-3.3A)
G39  A 509 (-3.6A)
G39  A 509 (-4.7A)
None
G39  A 509 ( 4.1A)
G39  A 509 ( 4.0A)
G39  A 509 (-2.8A)
G39  A 509 (-2.9A)
G39  A 509 (-4.6A)
0.47A 1a4gA-4hzzA:
52.3
1a4gA-4hzzA:
33.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hzz NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
7 GLU A 119
ARG A 224
GLU A 227
GLU A 276
GLU A 277
ASN A 294
TYR A 406
G39  A 509 (-3.3A)
G39  A 509 (-4.7A)
None
G39  A 509 ( 4.1A)
G39  A 509 ( 4.0A)
G39  A 509 ( 4.4A)
G39  A 509 (-4.6A)
1.06A 1a4gA-4hzzA:
52.3
1a4gA-4hzzA:
33.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jf7 HEMAGGLUTININ-NEURAM
INIDASE


(Mammalian
rubulavirus 5)
no annotation 6 ARG D 163
GLU D 390
ARG D 405
ASN D 407
ARG D 495
TYR D 523
SO4  D 608 ( 4.1A)
None
SO4  D 608 (-2.6A)
None
SO4  D 608 (-3.3A)
None
0.87A 1a4gA-4jf7D:
22.4
1a4gA-4jf7D:
21.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mju NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
8 ARG A 118
ARG A 224
GLU A 227
ALA A 246
GLU A 276
GLU A 277
ASN A 294
TYR A 406
27S  A 501 (-3.0A)
27S  A 501 (-4.3A)
27S  A 501 (-3.3A)
27S  A 501 ( 3.8A)
27S  A 501 ( 3.7A)
27S  A 501 (-3.4A)
27S  A 501 (-3.6A)
27S  A 501 (-4.6A)
0.73A 1a4gA-4mjuA:
52.2
1a4gA-4mjuA:
36.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mju NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
9 ARG A 118
ARG A 224
GLU A 227
ALA A 246
GLU A 277
ARG A 292
ASN A 294
ARG A 371
TYR A 406
27S  A 501 (-3.0A)
27S  A 501 (-4.3A)
27S  A 501 (-3.3A)
27S  A 501 ( 3.8A)
27S  A 501 (-3.4A)
27S  A 501 (-3.1A)
27S  A 501 (-3.6A)
27S  A 501 (-3.1A)
27S  A 501 (-4.6A)
0.51A 1a4gA-4mjuA:
52.2
1a4gA-4mjuA:
36.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mju NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
5 ARG A 118
ASP A 151
ARG A 224
GLU A 227
GLU A 277
27S  A 501 (-3.0A)
27S  A 501 (-3.2A)
27S  A 501 (-4.3A)
27S  A 501 (-3.3A)
27S  A 501 (-3.4A)
0.79A 1a4gA-4mjuA:
52.2
1a4gA-4mjuA:
36.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mju NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
7 GLU A 119
ARG A 224
ALA A 246
GLU A 276
GLU A 277
ASN A 294
TYR A 406
27S  A 501 (-3.4A)
27S  A 501 (-4.3A)
27S  A 501 ( 3.8A)
27S  A 501 ( 3.7A)
27S  A 501 (-3.4A)
27S  A 501 (-3.6A)
27S  A 501 (-4.6A)
1.17A 1a4gA-4mjuA:
52.2
1a4gA-4mjuA:
36.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mju NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
7 GLU A 119
ARG A 224
ALA A 246
GLU A 277
ARG A 292
ASN A 294
TYR A 406
27S  A 501 (-3.4A)
27S  A 501 (-4.3A)
27S  A 501 ( 3.8A)
27S  A 501 (-3.4A)
27S  A 501 (-3.1A)
27S  A 501 (-3.6A)
27S  A 501 (-4.6A)
1.05A 1a4gA-4mjuA:
52.2
1a4gA-4mjuA:
36.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mju NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
5 GLU A 227
ALA A 246
ARG A 292
ASN A 294
TYR A 406
27S  A 501 (-3.3A)
27S  A 501 ( 3.8A)
27S  A 501 (-3.1A)
27S  A 501 (-3.6A)
27S  A 501 (-4.6A)
1.22A 1a4gA-4mjuA:
52.2
1a4gA-4mjuA:
36.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n5f PUTATIVE ACYL-COA
DEHYDROGENASE


(Burkholderia
cenocepacia)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 ARG A  17
GLU A  75
ALA A 289
ARG A 296
ASN A 293
None
1.44A 1a4gA-4n5fA:
undetectable
1a4gA-4n5fA:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q6k BNR/ASP-BOX REPEAT
PROTEIN


(Bacteroides
caccae)
PF13088
(BNR_2)
PF14873
(BNR_assoc_N)
6 ARG A 220
ASP A 245
GLU A 415
ARG A 431
ARG A 495
TYR A 526
EDO  A 604 (-4.0A)
EDO  A 604 ( 4.3A)
None
None
None
None
0.42A 1a4gA-4q6kA:
24.9
1a4gA-4q6kA:
22.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qn3 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
12 ARG A  36
GLU A  37
ASP A  69
ARG A 143
GLU A 146
ALA A 165
GLU A 195
GLU A 196
ARG A 211
ASN A 213
ARG A 290
TYR A 324
None
0.64A 1a4gA-4qn3A:
53.6
1a4gA-4qn3A:
33.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4sli INTRAMOLECULAR
TRANS-SIALIDASE


(Macrobdella
decora)
PF02973
(Sialidase)
PF13088
(BNR_2)
5 ALA A 592
GLU A 595
ARG A 611
ARG A 673
TYR A 713
None
CNP  A 760 ( 4.5A)
CNP  A 760 (-3.0A)
CNP  A 760 (-3.0A)
CNP  A 760 (-4.0A)
1.06A 1a4gA-4sliA:
24.8
1a4gA-4sliA:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4sli INTRAMOLECULAR
TRANS-SIALIDASE


(Macrobdella
decora)
PF02973
(Sialidase)
PF13088
(BNR_2)
6 ARG A 293
ASP A 318
GLU A 595
ARG A 611
ARG A 673
TYR A 713
CNP  A 760 (-3.0A)
CNP  A 760 (-2.6A)
CNP  A 760 ( 4.5A)
CNP  A 760 (-3.0A)
CNP  A 760 (-3.0A)
CNP  A 760 (-4.0A)
0.58A 1a4gA-4sliA:
24.8
1a4gA-4sliA:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4txk PROTEIN-METHIONINE
SULFOXIDE OXIDASE
MICAL1


(Mus musculus)
PF00307
(CH)
PF01494
(FAD_binding_3)
5 ARG A 230
GLU A 373
ALA A 473
GLU A 437
ARG A 371
None
1.21A 1a4gA-4txkA:
undetectable
1a4gA-4txkA:
22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x6k ANHYDROSIALIDASE

([Ruminococcus]
gnavus)
PF13088
(BNR_2)
5 ALA A 556
GLU A 559
ARG A 575
ARG A 637
TYR A 677
None
3XR  A 802 ( 4.7A)
3XR  A 802 (-2.6A)
3XR  A 802 (-3.0A)
3XR  A 802 (-4.2A)
1.01A 1a4gA-4x6kA:
21.1
1a4gA-4x6kA:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x6k ANHYDROSIALIDASE

([Ruminococcus]
gnavus)
PF13088
(BNR_2)
6 ARG A 257
ASP A 282
GLU A 559
ARG A 575
ARG A 637
TYR A 677
3XR  A 802 (-3.0A)
3XR  A 802 (-2.5A)
3XR  A 802 ( 4.7A)
3XR  A 802 (-2.6A)
3XR  A 802 (-3.0A)
3XR  A 802 (-4.2A)
0.58A 1a4gA-4x6kA:
21.1
1a4gA-4x6kA:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xhb SIALIDASE B

(Streptococcus
pneumoniae)
PF02012
(BNR)
PF02973
(Sialidase)
PF13088
(BNR_2)
5 ALA A 538
GLU A 541
ARG A 557
ARG A 619
TYR A 653
None
None
NHE  A 702 (-2.8A)
NHE  A 702 (-2.9A)
NHE  A 702 (-4.8A)
1.20A 1a4gA-4xhbA:
22.5
1a4gA-4xhbA:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xhb SIALIDASE B

(Streptococcus
pneumoniae)
PF02012
(BNR)
PF02973
(Sialidase)
PF13088
(BNR_2)
6 ARG A 245
ASP A 270
GLU A 541
ARG A 557
ARG A 619
TYR A 653
NHE  A 702 (-2.7A)
NHE  A 702 (-3.2A)
None
NHE  A 702 (-2.8A)
NHE  A 702 (-2.9A)
NHE  A 702 (-4.8A)
0.59A 1a4gA-4xhbA:
22.5
1a4gA-4xhbA:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yw5 NEURAMINIDASE C

(Streptococcus
pneumoniae)
PF02012
(BNR)
PF02973
(Sialidase)
PF13088
(BNR_2)
6 ARG A 290
ASP A 315
GLU A 584
ARG A 600
ARG A 662
TYR A 695
G39  A 801 (-2.6A)
G39  A 801 (-3.2A)
G39  A 801 ( 4.7A)
G39  A 801 (-2.9A)
G39  A 801 (-2.9A)
G39  A 801 (-4.4A)
0.71A 1a4gA-4yw5A:
23.8
1a4gA-4yw5A:
20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b2d HN PROTEIN

(Mumps
rubulavirus)
PF00423
(HN)
5 ARG A 180
GLU A 407
ARG A 422
ARG A 512
TYR A 540
SLT  A 606 (-2.6A)
SLT  A 606 (-3.8A)
SLT  A 606 (-3.0A)
SLT  A 606 (-2.8A)
SLT  A 606 (-4.7A)
0.52A 1a4gA-5b2dA:
22.5
1a4gA-5b2dA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5czz CRISPR-ASSOCIATED
ENDONUCLEASE CAS9


(Staphylococcus
aureus)
PF13395
(HNH_4)
PF16592
(Cas9_REC)
5 ARG A  92
GLU A 179
ALA A 144
ASN A 141
TYR A 176
None
1.33A 1a4gA-5czzA:
undetectable
1a4gA-5czzA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dot CARBAMOYL-PHOSPHATE
SYNTHASE [AMMONIA],
MITOCHONDRIAL


(Homo sapiens)
PF00117
(GATase)
PF00988
(CPSase_sm_chain)
PF02142
(MGS)
PF02786
(CPSase_L_D2)
PF02787
(CPSase_L_D3)
5 ARG A 929
ASP A 914
ARG A 814
GLU A1034
ARG A1039
None
None
EDO  A1603 (-3.9A)
EDO  A1603 (-2.7A)
EDO  A1603 ( 3.8A)
1.30A 1a4gA-5dotA:
undetectable
1a4gA-5dotA:
13.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iq6 RNA DEPENDENT RNA
POLYMERASE


(Dengue virus)
PF00972
(Flavi_NS5)
5 ARG A 438
GLU A 486
ARG A 391
GLU A 397
TYR A 482
None
1.47A 1a4gA-5iq6A:
undetectable
1a4gA-5iq6A:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u22 N2152

(Neocallimastix
frontalis)
PF01229
(Glyco_hydro_39)
5 ALA A 219
GLU A 151
GLU A 110
ARG A  76
ASN A 253
None
1.38A 1a4gA-5u22A:
undetectable
1a4gA-5u22A:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y7i CHLORIDE
INTRACELLULAR
CHANNEL PROTEIN 2


(Oreochromis
mossambicus)
no annotation 5 GLU A  88
ALA A 180
GLU A  87
ARG A  35
ASN A 183
None
1.19A 1a4gA-5y7iA:
undetectable
1a4gA-5y7iA:
9.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6br6 NEURAMINIDASE

(Influenza A
virus)
no annotation 12 ARG A 118
GLU A 119
ASP A 151
ARG A 224
GLU A 227
ALA A 246
GLU A 276
GLU A 277
ARG A 292
ASN A 294
ARG A 371
TYR A 406
E3M  A 511 (-3.0A)
E3M  A 511 (-3.6A)
E3M  A 511 (-2.9A)
E3M  A 511 (-3.8A)
E3M  A 511 ( 4.8A)
E3M  A 511 (-3.1A)
E3M  A 511 (-2.3A)
E3M  A 511 ( 3.6A)
E3M  A 511 (-2.9A)
E3M  A 511 ( 3.1A)
E3M  A 511 (-2.9A)
E3M  A 511 (-4.5A)
0.51A 1a4gA-6br6A:
54.5
1a4gA-6br6A:
10.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eks SIALIDASE

(Vibrio cholerae)
no annotation 6 ARG A 250
ASP A 276
GLU A 645
ARG A 661
ARG A 738
TYR A 766
G39  A 908 (-2.8A)
G39  A 908 (-3.3A)
G39  A 908 (-4.0A)
G39  A 908 (-2.8A)
G39  A 908 (-3.0A)
G39  A 908 (-4.6A)
0.39A 1a4gA-6eksA:
13.8
1a4gA-6eksA:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6es9 ACYL-COA
DEHYDROGENASE


(Paracoccus
denitrificans)
no annotation 5 ARG A  73
GLU A 477
GLU A  70
GLU A 487
ARG A 548
None
1.36A 1a4gA-6es9A:
undetectable
1a4gA-6es9A:
9.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nmb N9 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG N 152
ARG N 156
TRP N 178
ILE N 222
None
0.37A 1a4gA-1nmbN:
53.6
1a4gA-1nmbN:
28.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1v0z NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG A 158
ARG A 162
TRP A 185
ILE A 229
None
0.19A 1a4gA-1v0zA:
53.8
1a4gA-1v0zA:
32.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1vcj NEURAMINIDASE

(Influenza B
virus)
PF00064
(Neur)
4 ARG A 150
ARG A 154
TRP A 177
ILE A 221
IBA  A   1 (-3.9A)
IBA  A   1 (-4.1A)
None
IBA  A   1 ( 4.3A)
0.41A 1a4gA-1vcjA:
73.9
1a4gA-1vcjA:
94.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1xog NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG A 153
ARG A 157
TRP A 180
ILE A 224
ABW  A1000 (-4.1A)
ABW  A1000 (-4.2A)
None
ABW  A1000 ( 4.7A)
0.42A 1a4gA-1xogA:
53.4
1a4gA-1xogA:
30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2htv NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG A 152
ARG A 156
TRP A 178
ILE A 222
None
0.43A 1a4gA-2htvA:
51.8
1a4gA-2htvA:
36.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ckz NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG A 152
ARG A 156
TRP A 178
ILE A 222
ZMR  A 469 (-3.9A)
ZMR  A 469 (-3.4A)
None
None
0.71A 1a4gA-3ckzA:
53.6
1a4gA-3ckzA:
34.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ti8 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG A 152
ARG A 156
TRP A 178
ILE A 222
LNV  A 901 (-4.0A)
LNV  A 901 (-4.0A)
None
None
0.12A 1a4gA-3ti8A:
53.9
1a4gA-3ti8A:
36.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tia NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG A 152
ARG A 156
TRP A 178
ILE A 222
LNV  A 801 (-3.9A)
LNV  A 801 (-4.0A)
None
None
0.14A 1a4gA-3tiaA:
55.2
1a4gA-3tiaA:
28.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4cpn NEURAMINIDASE

(Influenza B
virus)
PF00064
(Neur)
4 ARG A 149
ARG A 153
TRP A 176
ILE A 220
ZMR  A 700 (-4.0A)
ZMR  A 700 (-4.2A)
None
None
0.12A 1a4gA-4cpnA:
75.0
1a4gA-4cpnA:
94.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h53 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG A 152
ARG A 156
TRP A 178
ILE A 222
SLB  A 512 (-3.8A)
None
None
None
0.15A 1a4gA-4h53A:
55.1
1a4gA-4h53A:
31.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hzz NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG A 152
ARG A 156
TRP A 178
ILE A 222
G39  A 509 (-3.9A)
None
None
G39  A 509 ( 4.1A)
0.16A 1a4gA-4hzzA:
52.3
1a4gA-4hzzA:
33.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mju NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG A 152
ARG A 156
TRP A 178
ILE A 222
27S  A 501 (-4.2A)
None
None
27S  A 501 ( 4.6A)
0.64A 1a4gA-4mjuA:
52.2
1a4gA-4mjuA:
36.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qn3 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ARG A  70
ARG A  74
TRP A  97
ILE A 141
None
0.20A 1a4gA-4qn3A:
53.6
1a4gA-4qn3A:
33.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6br6 NEURAMINIDASE

(Influenza A
virus)
no annotation 4 ARG A 152
ARG A 156
TRP A 178
ILE A 222
E3M  A 511 (-3.8A)
None
None
E3M  A 511 ( 4.3A)
0.14A 1a4gA-6br6A:
54.5
1a4gA-6br6A:
10.51